Literature DB >> 11123863

Concurrent chemotherapy and radiation for locally advanced squamous cell cancers: what is the schedule of choice?

J H Schornagel1, M Verheij, H Bartelink.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11123863     DOI： 10.1007/s11912-001-0034-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  10 in total

1.  DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy.

Authors:  P J van de Vaart; J Belderbos; D de Jong; K C Sneeuw; D Majoor; H Bartelink; A C Begg
Journal:  Int J Cancer       Date:  2000-03-20       Impact factor: 7.396

2.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

3.  Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.

Authors:  K T Robbins; P Kumar; W F Regine; F S Wong; A B Weir; P Flick; L E Kun; R Palmer; T Murry; J Fontanesi; R Ferguson; R Thomas; W Hartsell; C U Paig; G Salazar; L Norfleet; C B Hanchett; V Harrington; H B Niell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-05-01       Impact factor: 7.038

4.  Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer.

Authors:  A L Uitterhoeve; J S Belderbos; M G Koolen; P J van der Vaart; P T Rodrigus; J Benraadt; C C Koning; D González González; H Bartelink
Journal:  Eur J Cancer       Date:  2000-03       Impact factor: 9.162

5.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

Authors:  M Morris; P J Eifel; J Lu; P W Grigsby; C Levenback; R E Stevens; M Rotman; D M Gershenson; D G Mutch
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245

6.  Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

Authors:  P G Rose; B N Bundy; E B Watkins; J T Thigpen; G Deppe; M A Maiman; D L Clarke-Pearson; S Insalaco
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245

Review 7.  Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care.

Authors:  G M Thomas
Journal:  Semin Radiat Oncol       Date:  2000-01       Impact factor: 5.934

8.  Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.

Authors:  H M Keys; B N Bundy; F B Stehman; L I Muderspach; W E Chafe; C L Suggs; J L Walker; D Gersell
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245

9.  Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study.

Authors:  M Al-Sarraf; T F Pajak; V A Marcial; P Mowry; J S Cooper; J Stetz; J F Ensley; E Velez-Garcia
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

10.  Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer.

Authors:  C Schaake-Koning; W van den Bogaert; O Dalesio; J Festen; J Hoogenhout; P van Houtte; A Kirkpatrick; M Koolen; B Maat; A Nijs
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.